GFAP and amyotrophic lateral sclerosis: While the amount of GFAP expression was not different between OrgCtrl cerebral organoids injected with control or ALS patient-derived protein extract, a significant difference in GFAP expression was seen in OrgALS cerebral organoids (Fig 4D and 4E).